OVERVIEW

Matching Treatment Options to the Patient: The Role of Botulinum Toxin in Pediatric Patients with Spasticity is organized by CME Outfitters, LLC.

Premiere Date: Thursday, June 11, 2020
Credit Expiration Date: Friday, June 11, 2022

Target Audience:
Physicians, PAs, nurse practitioners, and pharmacists.

This activity offers CE credit for:
• Physicians (CME)
• Pharmacists (ACPE)
• ABIM (MOC)
• Other

Statement of Need:
Spasticity, known as a motor disorder characterized by an increase in velocity-dependent tonic stretch reflexes with exaggerated tendon jerks, and spasms are caused by hyperexcitability of the stretch reflex. Because MS frequently damages one or more parts of the central nervous system, therapeutic goals should include symptom relief, making patient care easier and reducing caregiver strain, as well as improving patient function. Clinicians must design tailored treatment plans based on collaborative decision-making, available treatment alternatives, and patient-specific considerations in order to achieve these aims.

This illuminative CMEOCast podcast episode discusses how to best match treatment alternatives to patients, Featuring a special focus on the safety and efficacy of botulinum toxin as a spasticity treatment.

Learning Objectives:
In order to complete this illuminative CME/CE, participants will be better able to:
• Learn how to recognize the symptoms of spasticity.
• Create tailored therapy plans based on shared goals, treatment alternatives, and patient-specific characteristics.

The learning goals listed below are only for those individuals seeking CNE or CPE credit:
• Understand the signs and symptoms of spasticity.
• Outline customized treatment plans well-based on common goals, treatment choices, and patient-specific characteristics.